BioCentury | Feb 13, 2006
Finance

Ebb & Flow

...will proceed." CVTX expects to launch Ranexa in late March. Buyside tracks Investment management firm Scout Capital...
BioCentury | May 13, 2002
Company News

Synsorb board of directors update

...TSE:SYB; SYBB), Calgary, Alberta Business: Infectious diseases, Cancer Appointed: David Tonken, president and CEO of Scout Capital...
...remain as a director; Jim Silye, president and CEO; and Tim Tycholis, a director of Scout Capital...
BioCentury | Jan 7, 2002
Financial News

Alteon raises $18.9 million

...million shares at $4.25. Investors included Fiduciary Trust; Merlin BioMed; SDS Merchant Fund; Oracle Partners; Scout Capital...
Items per page:
1 - 3 of 3
BioCentury | Feb 13, 2006
Finance

Ebb & Flow

...will proceed." CVTX expects to launch Ranexa in late March. Buyside tracks Investment management firm Scout Capital...
BioCentury | May 13, 2002
Company News

Synsorb board of directors update

...TSE:SYB; SYBB), Calgary, Alberta Business: Infectious diseases, Cancer Appointed: David Tonken, president and CEO of Scout Capital...
...remain as a director; Jim Silye, president and CEO; and Tim Tycholis, a director of Scout Capital...
BioCentury | Jan 7, 2002
Financial News

Alteon raises $18.9 million

...million shares at $4.25. Investors included Fiduciary Trust; Merlin BioMed; SDS Merchant Fund; Oracle Partners; Scout Capital...
Items per page:
1 - 3 of 3